Market Alert: Rosetta Genomics, (NASDAQ:ROSG), JetPay Corporation (NASDAQ:JTPY), Heidrick & Struggles International Inc. (NASDAQ:HSII), CIFC Corp. (NASDAQ:CIFC), Vermillion (NASDAQ:VRML)


Rosetta Genomics Ltd. (NASDAQ:ROSG) a leading developer and provider of microRNA-based molecular diagnostics, announces the publication of an article in the Journal of Kidney Cancer in support of the use of the Rosetta Kidney Cancer Test™. Titled “Clinicians’ Real World Perceptions of Pre-Nephrectomy Diagnostic Biopsy Performance as a Driver of Reduction in Unnecessary Surgeries in Renal Tumors,” the article appeared in the online edition on January 18, 2015. On Friday shares of Rosetta Genomics, Ltd. (NASDAQ:ROSG) closed at $2.95. Company’s EPS growth for next 5 years is recorded as 25.00%.

JetPay Corporation (NASDAQ: JTPY), a leading provider of debit and credit card processing, payroll and prepaid card services, Tuesday, 20 January 2015 announced that it has added Ingo™ Money as a new and convenient funding method to its Money Access Card® (MAC) Prepaid Visa®. JetPay Corporation (NASDAQ:JTPY) in last trading activity fell -2.50% to close at $2.34. Company weekly performance is 0.86% while its quarterly performance stands at 30.00%. JetPay Corporation (NASDAQ:JTPY) is -44.29% away from its 52 week high.

Macquarie upgraded shares of Heidrick & Struggles International (NASDAQ:HSII) from an underperform rating to a neutral rating in a research note released on Wednesday, 7 January 2015 morning. On last trading day Heidrick & Struggles International Inc. (NASDAQ:HSII) fell -0.35% to close at $22.81. Its volatility for the week is 2.93% while volatility for the month is 3.19%. HSII’s sales growth for past 5 years was -5.60% and its EPS growth for past 5 years was -30.80%. Heidrick & Struggles International Inc. (NASDAQ:HSII) monthly performance is 0.71%.

CIFC Corp. (NASDAQ:CIFC) and its subsidiaries (collectively “CIFC” or the “Company”) announced the closing of a new CIFC-managed CLO, CIFC Funding 2014-V, LTD., representing $559.9 million of par and approximately $550 million of new Assets Under Management (“AUM”). The transaction was led by RBC Capital Markets, LLC and supported by fourteen institutional investors, including some first time investors with CIFC. CIFC Corp. (NASDAQ:CIFC) has 1.40% insider ownership while its institutional ownership stands at 9.70%. In last trading activity company’s stock closed at $8.67.

Vermillion, Inc. (NASDAQ:VRML) has appointed Laura Millerits senior vice president of sales and customer experience, a new position created at the Austin-based medical diagnostics company. On last trading day Vermillion, Inc. (NASDAQ:VRML) advanced 1.09% to close at $1.85. Its volatility for the week is 9.08% while volatility for the month is 7.78%. VRML’s sales growth for past 5 years was 91.90% and its EPS growth for past 5 years was 31.90%. Vermillion, Inc. (NASDAQ:VRML) monthly performance is 25.00%.


Leave a Reply

Your email address will not be published. Required fields are marked *